Search

Author/Creator Castagnari, Barbara

1. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022)

Authors:
Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar...
Journal:
Lancet
Issue:
Volume 9:Issue 6(2022)
Page Start:
e403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study. (8th November 2018)

Authors:
Iannitto, Emilio; Bellei, Monica; Amorim, Sandy; Ferreri, Andrés J. M.; Marcheselli, Luigi; Cesaretti, Marina; Haioun, Corinne; Mancuso, Salvatrice; Bouabdallah, Krimo; Gressin, Remy; Tripodo, Claudio; Traverse‐Glehen, Alexandra; Baseggio, Lucile; Zupo, Simonetta; Stelitano, Caterina; Castagnari,...
Journal:
British journal of haematology
Issue:
Volume 183:Number 5(2018)
Page Start:
755
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search